SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Aegerion Pharmaceuticals, Inc. to Contact Brower Piven Before the March 17, 2014 Lead Plaintiff Deadline